Cancer cell-specific oligopeptides selected by an integrated microfluidic system from a phage display library for ovarian cancer diagnosis

Chih Hung Wang, Chen Hsun Weng, Yu Jui Che, Kuan Wang, Gwo Bin Lee

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Ovarian cancer is one of the leading causes of female mortality worldwide. Unfortunately, there are currently few high-specificity candidate oligopeptide targeting agents that can be used for early diagnosis of this cancer. It has been suggested that cancer-specific oligopeptides could be screened from a phage display library. However, conventional methods are tedious, labor-intensive, and time consuming. Therefore, a novel, integrated microfluidic system was developed to automate the entire screening process for ovarian cancer cell-specific oligopeptides. An oligopeptide screened with microfluidic chip-based technique was demonstrated to have high affinity to ovarian cancer cells and demonstrated relatively low binding to other cancer cells, indicating a high specificity. Furthermore, the developed method consumed relatively low volumes of samples and reagents; only 70 μL of reactant was used within the whole experimental process. Each panning process was also significantly shortened to only 7.5 hours. Therefore, the screened oligopeptide could be used to isolate ovarian cancer cells in a rapid manner, thus greatly expediting the diagnosis and its application as oligopeptide targeting agent for theranostics of this cancer.

Original languageEnglish
Pages (from-to)431-442
Number of pages12
JournalTheranostics
Volume5
Issue number4
DOIs
Publication statusPublished - Jan 1 2015
Externally publishedYes

Fingerprint

Peptide Library
Oligopeptides
Microfluidics
Tumor Cell Line
Routine Diagnostic Tests
Protein Binding
Ovarian Neoplasms
Bacteriophages
Libraries
Neoplasms
Early Detection of Cancer
Mortality

Keywords

  • Microfluidic chip
  • Oligopeptide targeting agent
  • Ovarian cancer
  • Phage display library

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Cite this

Cancer cell-specific oligopeptides selected by an integrated microfluidic system from a phage display library for ovarian cancer diagnosis. / Wang, Chih Hung; Weng, Chen Hsun; Che, Yu Jui; Wang, Kuan; Lee, Gwo Bin.

In: Theranostics, Vol. 5, No. 4, 01.01.2015, p. 431-442.

Research output: Contribution to journalArticle

@article{786c329d74cd4da5b928b5082f7bf210,
title = "Cancer cell-specific oligopeptides selected by an integrated microfluidic system from a phage display library for ovarian cancer diagnosis",
abstract = "Ovarian cancer is one of the leading causes of female mortality worldwide. Unfortunately, there are currently few high-specificity candidate oligopeptide targeting agents that can be used for early diagnosis of this cancer. It has been suggested that cancer-specific oligopeptides could be screened from a phage display library. However, conventional methods are tedious, labor-intensive, and time consuming. Therefore, a novel, integrated microfluidic system was developed to automate the entire screening process for ovarian cancer cell-specific oligopeptides. An oligopeptide screened with microfluidic chip-based technique was demonstrated to have high affinity to ovarian cancer cells and demonstrated relatively low binding to other cancer cells, indicating a high specificity. Furthermore, the developed method consumed relatively low volumes of samples and reagents; only 70 μL of reactant was used within the whole experimental process. Each panning process was also significantly shortened to only 7.5 hours. Therefore, the screened oligopeptide could be used to isolate ovarian cancer cells in a rapid manner, thus greatly expediting the diagnosis and its application as oligopeptide targeting agent for theranostics of this cancer.",
keywords = "Microfluidic chip, Oligopeptide targeting agent, Ovarian cancer, Phage display library",
author = "Wang, {Chih Hung} and Weng, {Chen Hsun} and Che, {Yu Jui} and Kuan Wang and Lee, {Gwo Bin}",
year = "2015",
month = "1",
day = "1",
doi = "10.7150/thno.10891",
language = "English",
volume = "5",
pages = "431--442",
journal = "Theranostics",
issn = "1838-7640",
publisher = "Ivyspring International Publisher",
number = "4",

}

TY - JOUR

T1 - Cancer cell-specific oligopeptides selected by an integrated microfluidic system from a phage display library for ovarian cancer diagnosis

AU - Wang, Chih Hung

AU - Weng, Chen Hsun

AU - Che, Yu Jui

AU - Wang, Kuan

AU - Lee, Gwo Bin

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Ovarian cancer is one of the leading causes of female mortality worldwide. Unfortunately, there are currently few high-specificity candidate oligopeptide targeting agents that can be used for early diagnosis of this cancer. It has been suggested that cancer-specific oligopeptides could be screened from a phage display library. However, conventional methods are tedious, labor-intensive, and time consuming. Therefore, a novel, integrated microfluidic system was developed to automate the entire screening process for ovarian cancer cell-specific oligopeptides. An oligopeptide screened with microfluidic chip-based technique was demonstrated to have high affinity to ovarian cancer cells and demonstrated relatively low binding to other cancer cells, indicating a high specificity. Furthermore, the developed method consumed relatively low volumes of samples and reagents; only 70 μL of reactant was used within the whole experimental process. Each panning process was also significantly shortened to only 7.5 hours. Therefore, the screened oligopeptide could be used to isolate ovarian cancer cells in a rapid manner, thus greatly expediting the diagnosis and its application as oligopeptide targeting agent for theranostics of this cancer.

AB - Ovarian cancer is one of the leading causes of female mortality worldwide. Unfortunately, there are currently few high-specificity candidate oligopeptide targeting agents that can be used for early diagnosis of this cancer. It has been suggested that cancer-specific oligopeptides could be screened from a phage display library. However, conventional methods are tedious, labor-intensive, and time consuming. Therefore, a novel, integrated microfluidic system was developed to automate the entire screening process for ovarian cancer cell-specific oligopeptides. An oligopeptide screened with microfluidic chip-based technique was demonstrated to have high affinity to ovarian cancer cells and demonstrated relatively low binding to other cancer cells, indicating a high specificity. Furthermore, the developed method consumed relatively low volumes of samples and reagents; only 70 μL of reactant was used within the whole experimental process. Each panning process was also significantly shortened to only 7.5 hours. Therefore, the screened oligopeptide could be used to isolate ovarian cancer cells in a rapid manner, thus greatly expediting the diagnosis and its application as oligopeptide targeting agent for theranostics of this cancer.

KW - Microfluidic chip

KW - Oligopeptide targeting agent

KW - Ovarian cancer

KW - Phage display library

UR - http://www.scopus.com/inward/record.url?scp=84924284077&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924284077&partnerID=8YFLogxK

U2 - 10.7150/thno.10891

DO - 10.7150/thno.10891

M3 - Article

C2 - 25699101

AN - SCOPUS:84924284077

VL - 5

SP - 431

EP - 442

JO - Theranostics

JF - Theranostics

SN - 1838-7640

IS - 4

ER -